Search Results

You are looking at 1 - 10 of 26 items for :

  • malignant pheochromocytoma x
  • Refine by access: Open Access content only x
Clear All
WenQi Yuan Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China
Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China

Search for other papers by WenQi Yuan in
Google Scholar
PubMed
Close
,
WeiQinq Wang Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China
Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China

Search for other papers by WeiQinq Wang in
Google Scholar
PubMed
Close
,
Bin Cui Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China
Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China

Search for other papers by Bin Cui in
Google Scholar
PubMed
Close
,
TingWei Su Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China

Search for other papers by TingWei Su in
Google Scholar
PubMed
Close
,
Yan Ge Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China
Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China

Search for other papers by Yan Ge in
Google Scholar
PubMed
Close
,
Lei Jiang Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China

Search for other papers by Lei Jiang in
Google Scholar
PubMed
Close
,
WeiWei Zhou Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China

Search for other papers by WeiWei Zhou in
Google Scholar
PubMed
Close
, and
Guang Ning Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China
Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China
Department of Endocrine and Metabolic Diseases, Laboratory of Endocrine and Metabolic Diseases, Division of Endocrine and Metabolic Diseases, School of Medicine, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University, 197 Ruijin Er Lu, Shanghai 200025, People's Republic of China

Search for other papers by Guang Ning in
Google Scholar
PubMed
Close

similar to those detected by CGH analysis. The most obvious was the gain of erythroblastic leukemia viral oncogene homolog 2 ( ERBB-2 ) oncogene located on chromosome 17q that was more common in malignant pheochromocytomas. Moreover, we analyzed the ERBB

Open access
Samuel M O’Toole William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK
Department of Endocrinology, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

Search for other papers by Samuel M O’Toole in
Google Scholar
PubMed
Close
,
David S Watson William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by David S Watson in
Google Scholar
PubMed
Close
,
Tatiana V Novoselova William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by Tatiana V Novoselova in
Google Scholar
PubMed
Close
,
Lisa E L Romano William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by Lisa E L Romano in
Google Scholar
PubMed
Close
,
Peter J King William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by Peter J King in
Google Scholar
PubMed
Close
,
Teisha Y Bradshaw William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by Teisha Y Bradshaw in
Google Scholar
PubMed
Close
,
Clare L Thompson Institute of Bioengineering and School of Engineering and Material Sciences, Queen Mary University of London, London, UK

Search for other papers by Clare L Thompson in
Google Scholar
PubMed
Close
,
Martin M Knight Institute of Bioengineering and School of Engineering and Material Sciences, Queen Mary University of London, London, UK

Search for other papers by Martin M Knight in
Google Scholar
PubMed
Close
,
Tyson V Sharp Barts Cancer Institute, Queen Mary University of London, London, UK

Search for other papers by Tyson V Sharp in
Google Scholar
PubMed
Close
,
Michael R Barnes William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by Michael R Barnes in
Google Scholar
PubMed
Close
,
Umasuthan Srirangalingam William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK
Department of Endocrinology, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Department of Diabetes and Endocrinology, University College London Hospital, London, UK

Search for other papers by Umasuthan Srirangalingam in
Google Scholar
PubMed
Close
,
William M Drake Department of Endocrinology, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

Search for other papers by William M Drake in
Google Scholar
PubMed
Close
, and
J Paul Chapple William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK

Search for other papers by J Paul Chapple in
Google Scholar
PubMed
Close

.1016/j.ccell.2017.01.009 ) 28196587 10.1016/j.ccell.2017.01.009 Dannenberg H De Krijger RR van der Harst E Abbou M Ijzendoorn Y Komminoth P Dinjens WN 2003 Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas

Open access
Tiantian Liu
Search for other papers by Tiantian Liu in
Google Scholar
PubMed
Close
,
Taylor C Brown Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by Taylor C Brown in
Google Scholar
PubMed
Close
,
C Christofer Juhlin Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Close
,
Adam Andreasson Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by Adam Andreasson in
Google Scholar
PubMed
Close
,
Na Wang Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by Na Wang in
Google Scholar
PubMed
Close
,
Martin Bäckdahl Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by Martin Bäckdahl in
Google Scholar
PubMed
Close
,
James M Healy Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by James M Healy in
Google Scholar
PubMed
Close
,
Manju L Prasad Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by Manju L Prasad in
Google Scholar
PubMed
Close
,
Reju Korah Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by Reju Korah in
Google Scholar
PubMed
Close
,
Tobias Carling Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden
Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by Tobias Carling in
Google Scholar
PubMed
Close
,
Dawei Xu
Search for other papers by Dawei Xu in
Google Scholar
PubMed
Close
, and
Catharina Larsson Department of Medicine-Solna, Yale Endocrine Neoplasia Laboratory, Department of Surgery, Departments of Oncology-Pathology, Molecular Medicine and Surgery, Department of Pathology, Karolinska Institutet, Karolinska University Hospital CMM, SE-171 76 Stockholm, Sweden

Search for other papers by Catharina Larsson in
Google Scholar
PubMed
Close

%) 4/81 (5%)  Adrenocortical carcinoma (ACC) 3/27 (11%) 1/7 (14%) 4/34 (12%)  Adrenocortical adenoma (ACA) 0/21 0/26 0/47 Pheochromocytoma (PCC) 0/86 1/19 (5%) 1/105 (1%)  Malignant PCC a 0/10 – 0/10  Benign PCC 0

Open access
Nimrod B Kiss Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden
Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Nimrod B Kiss in
Google Scholar
PubMed
Close
,
Andreas Muth Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Andreas Muth in
Google Scholar
PubMed
Close
,
Adam Andreasson Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden
Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Adam Andreasson in
Google Scholar
PubMed
Close
,
C Christofer Juhlin Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden
Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Close
,
Janos Geli Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Janos Geli in
Google Scholar
PubMed
Close
,
Martin Bäckdahl Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Martin Bäckdahl in
Google Scholar
PubMed
Close
,
Anders Höög Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Anders Höög in
Google Scholar
PubMed
Close
,
Bo Wängberg Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Bo Wängberg in
Google Scholar
PubMed
Close
,
Ola Nilsson Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Ola Nilsson in
Google Scholar
PubMed
Close
,
Håkan Ahlman Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Håkan Ahlman in
Google Scholar
PubMed
Close
, and
Catharina Larsson Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden
Department of Molecular Medicine and Surgery, Cancer Centre Karolinska, Department of Surgery, Department of Oncology–Pathology, Department of Pathology, Karolinska Institutet, Karolinska University Hospital, CCK R8:04, SE-171 76 Stockholm, Sweden

Search for other papers by Catharina Larsson in
Google Scholar
PubMed
Close

extended tumor panel of pheochromocytomas and paragangliomas. Notably and as our previous findings indicated a presence of CIMP in strong association with malignant paragangliomas with SDHB mutation ( Geli et al . 2008 , Kiss et al . 2008 ), the

Open access
Camilo Jimenez University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Camilo Jimenez in
Google Scholar
PubMed
Close
,
Bennett B Chin University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

Search for other papers by Bennett B Chin in
Google Scholar
PubMed
Close
,
Richard B Noto Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

Search for other papers by Richard B Noto in
Google Scholar
PubMed
Close
,
Joseph S Dillon University of Iowa, Iowa City, Iowa, USA

Search for other papers by Joseph S Dillon in
Google Scholar
PubMed
Close
,
Lilja Solnes Johns Hopkins Medicine, Baltimore, Maryland, USA

Search for other papers by Lilja Solnes in
Google Scholar
PubMed
Close
,
Nancy Stambler Progenics Pharmaceuticals, Inc., a Lantheus Company, North Billerica, Massachusetts, USA

Search for other papers by Nancy Stambler in
Google Scholar
PubMed
Close
,
Vincent A DiPippo Progenics Pharmaceuticals, Inc., a Lantheus Company, North Billerica, Massachusetts, USA

Search for other papers by Vincent A DiPippo in
Google Scholar
PubMed
Close
, and
Daniel A Pryma Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA

Search for other papers by Daniel A Pryma in
Google Scholar
PubMed
Close

Babich JW 2009 Radiation dosimetry, pharmacokinetics, and safety of ultratrace iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid . Cancer Biotherapy and Radiopharmaceuticals 24 469 – 475 . ( https

Open access
Diana E Benn Cancer Genetics, Kolling Institute, Royal North Shore Hospital, University of Sydney, St Leonards, New South Wales 2065, Australia

Search for other papers by Diana E Benn in
Google Scholar
PubMed
Close
,
Bruce G Robinson Cancer Genetics, Kolling Institute, Royal North Shore Hospital, University of Sydney, St Leonards, New South Wales 2065, Australia

Search for other papers by Bruce G Robinson in
Google Scholar
PubMed
Close
, and
Roderick J Clifton-Bligh Cancer Genetics, Kolling Institute, Royal North Shore Hospital, University of Sydney, St Leonards, New South Wales 2065, Australia

Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Close

Rieubland C Crespin M Nau V Khau VanKien P Corvol P Plouin PF Jeunemaitre X 2003 Mutations in the SDHB gene are associated with extra-adrenal and/or malignant pheochromocytomas . Cancer Research 63 5615 – 5621 . Gimenez

Open access
Liang Zhang Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Liang Zhang in
Google Scholar
PubMed
Close
,
Tobias Åkerström Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Close
,
Kazhan Mollazadegan Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Close
,
Felix Beuschlein Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich (USZ) and Univeristät Zürich (UZH), Zurich, Switzerland
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Close
,
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed
Close
,
Britt Skogseid Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Close
, and
Joakim Crona Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Joakim Crona in
Google Scholar
PubMed
Close

Oncology Reports 24 89 – 98 . ( https://doi.org/10.1007/s11912-022-01197-0 ) Kim JK Kim BH Baek SM Shin DH Kim WJ Jeon YK Kim SS & Kim IJ 2014 Incidentally detected inoperable malignant pheochromocytoma with hepatic metastasis treated by

Open access
Anne-Paule Gimenez-Roqueplo Université Paris Cité, PARCC, INSERM, Paris, France
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Close
,
Mercedes Robledo Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain

Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Close
, and
Patricia L M Dahia Division of Hematology and Medical Oncology, Department Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas, USA
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA

Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Close

First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): an academic double-blind trial investigating sunitinib . Annals of Oncology 32 S621. ( https://doi.org/10.1016/j.annonc.2021.08.702 ) Ben

Open access
Ruth T Casey Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge, UK
Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Close
,
Benjamin G Challis Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by Benjamin G Challis in
Google Scholar
PubMed
Close
,
Alison Marker Department of Histopathology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by Alison Marker in
Google Scholar
PubMed
Close
,
Deborah Pitfield Department of Endocrinology, Cambridge University NHS Foundation Trust, Cambridge, UK

Search for other papers by Deborah Pitfield in
Google Scholar
PubMed
Close
,
Heok K Cheow Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

Search for other papers by Heok K Cheow in
Google Scholar
PubMed
Close
,
Ashley Shaw Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

Search for other papers by Ashley Shaw in
Google Scholar
PubMed
Close
,
Soo-Mi Park Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge, UK

Search for other papers by Soo-Mi Park in
Google Scholar
PubMed
Close
,
Helen L Simpson Department of Diabetes and Endocrinology, University College London Hospitals, NHS Foundation Trust, London, UK

Search for other papers by Helen L Simpson in
Google Scholar
PubMed
Close
, and
Eamonn R Maher Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge, UK

Search for other papers by Eamonn R Maher in
Google Scholar
PubMed
Close

, we report a further case of a malignant PGL in a 46-year-old man with a succinate dehydrogenase complex flavoprotein subunit A ( SDHA ) germline mutation (c.91C > T, p.Arg31*). In the case we describe, following the initial surgical removal of a left

Open access
Susan Richter Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Susan Richter in
Google Scholar
PubMed
Close
,
Timothy J Garrett Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA

Search for other papers by Timothy J Garrett in
Google Scholar
PubMed
Close
,
Nicole Bechmann Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Nicole Bechmann in
Google Scholar
PubMed
Close
,
Roderick J Clifton-Bligh Cancer Genetics Laboratory, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, St Leonards, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia

Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Close
, and
Hans K Ghayee Department of Internal Medicine, Division of Endocrinology, University of Florida College of Medicine and Malcom Randall VA Medical Center, Gainesville, Florida, USA

Search for other papers by Hans K Ghayee in
Google Scholar
PubMed
Close

regression and stability with treatment ( Joshua et al. 2009 ). Newer data from the First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP, NCT01371201) indicate that 35.9% of patients with progressive

Open access